Tags

Type your tag names separated by a space and hit enter

[The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus].
Przegl Lek 1997; 54(7-8):533-9PL

Abstract

The aim of study was to evaluate bone mineral density (BMD) in lumbar spine (AP Spine), total body (Total Body) and distal site of radius (Forearm), and selected markers of bone formation: serum alkaline phosphatase (ALP) and osteocalcin(OC), and bone resorption: pyridinoline (PIR) and deoxy-pyridinoline (DPIR) in urine, in patients with long-standing insulin-dependent diabetes mellitus (IDDM), in comparison to healthy controls. Additionally, the influence of age, sex, smoking, duration of IDDM, the degree of metabolic control, or coexisting chronic complications of diabetes (retinopathy, incipient nephropathy, polyneuropathy) on the studied indices of bone metabolism in patients with IDDM were evaluated. The study was carried on 54 diabetic patients (23 F, 31 M) and 25 healthy individuals (13 F, 12 M). BMD was measured by DEXA (LUNAR DPX-L System). ALP was assessed by enzymatic method, and OC by RIA (Incstar Corporation). PIR and DPIR were assessed by EIA (Metra Biosystems). It was found that patients with long-standing IDDM have significantly lower BMD than healthy controls. The incidence rate of osteopenia and osteoporosis is significantly higher in this group of patients in comparison to the controls. In comparison to healthy subjects, patients with IDDM have significantly higher, but within normal reference range, serum ALP and OC, accompanied by similar PIR and not significantly increased DPIR. Duration and metabolic control of diabetes, or the coexistence of its chronic complications do not correlate with BMD or the studied indicies of bone turnover.

Authors+Show Affiliations

Kliniki Endokrynologii, Nadciśnienia Tetniczego i Chorób Przemiany Materii.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Controlled Clinical Trial
English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

pol

PubMed ID

9480464

Citation

Miazgowski, T, et al. "[The Evaluation of Bone Mineral Density and Selected Markers of Bone Turnover in Patients With Insulin Dependent Diabetes Mellitus]." Przeglad Lekarski, vol. 54, no. 7-8, 1997, pp. 533-9.
Miazgowski T, Andrysiak-Mamos E, Pynka S, et al. [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus]. Prz Lek. 1997;54(7-8):533-9.
Miazgowski, T., Andrysiak-Mamos, E., Pynka, S., Gulińska, M., & Czekalski, S. (1997). [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus]. Przeglad Lekarski, 54(7-8), pp. 533-9.
Miazgowski T, et al. [The Evaluation of Bone Mineral Density and Selected Markers of Bone Turnover in Patients With Insulin Dependent Diabetes Mellitus]. Prz Lek. 1997;54(7-8):533-9. PubMed PMID: 9480464.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus]. AU - Miazgowski,T, AU - Andrysiak-Mamos,E, AU - Pynka,S, AU - Gulińska,M, AU - Czekalski,S, PY - 1997/1/1/pubmed PY - 1998/2/28/medline PY - 1997/1/1/entrez SP - 533 EP - 9 JF - Przeglad lekarski JO - Prz. Lek. VL - 54 IS - 7-8 N2 - The aim of study was to evaluate bone mineral density (BMD) in lumbar spine (AP Spine), total body (Total Body) and distal site of radius (Forearm), and selected markers of bone formation: serum alkaline phosphatase (ALP) and osteocalcin(OC), and bone resorption: pyridinoline (PIR) and deoxy-pyridinoline (DPIR) in urine, in patients with long-standing insulin-dependent diabetes mellitus (IDDM), in comparison to healthy controls. Additionally, the influence of age, sex, smoking, duration of IDDM, the degree of metabolic control, or coexisting chronic complications of diabetes (retinopathy, incipient nephropathy, polyneuropathy) on the studied indices of bone metabolism in patients with IDDM were evaluated. The study was carried on 54 diabetic patients (23 F, 31 M) and 25 healthy individuals (13 F, 12 M). BMD was measured by DEXA (LUNAR DPX-L System). ALP was assessed by enzymatic method, and OC by RIA (Incstar Corporation). PIR and DPIR were assessed by EIA (Metra Biosystems). It was found that patients with long-standing IDDM have significantly lower BMD than healthy controls. The incidence rate of osteopenia and osteoporosis is significantly higher in this group of patients in comparison to the controls. In comparison to healthy subjects, patients with IDDM have significantly higher, but within normal reference range, serum ALP and OC, accompanied by similar PIR and not significantly increased DPIR. Duration and metabolic control of diabetes, or the coexistence of its chronic complications do not correlate with BMD or the studied indicies of bone turnover. SN - 0033-2240 UR - https://www.unboundmedicine.com/medline/citation/9480464/[The_evaluation_of_bone_mineral_density_and_selected_markers_of_bone_turnover_in_patients_with_insulin_dependent_diabetes_mellitus]_ L2 - http://www.diseaseinfosearch.org/result/2236 DB - PRIME DP - Unbound Medicine ER -